• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[婴儿期肝内胆汁淤积症患者的临床特征与基因变异]

[Clinical characteristics and gene variants of patients with infantile intrahepatic cholestasis].

作者信息

Wang Mei-Juan, Zhong Xue-Mei, Ma Xin, Ning Hui-Juan, Zhu Dan, Gong You-Zhe, Jin Meng

机构信息

Department of Gastroenterology, Children's Hospital, Capital Institute of Pediatrics, Beijing 100020, China.

出版信息

Zhongguo Dang Dai Er Ke Za Zhi. 2021 Jan;23(1):91-97. doi: 10.7499/j.issn.1008-8830.2009079.

DOI:10.7499/j.issn.1008-8830.2009079
PMID:33476544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7818162/
Abstract

OBJECTIVE

To explore the clinical characteristics and genetic findings of patients with infantile intrahepatic cholestasis.

METHODS

The clinical data were collected in children who were admitted to the Department of Gastroenterology in Children's Hospital, Capital Institute of Pediatrics from June 2017 to June 2019 and were suspected of inherited metabolic diseases. Next generation sequencing based on target gene panel was used for gene analysis in these children. Sanger sequencing technology was used to verify the genes of the members in this family.

RESULTS

Forty patients were enrolled. Pathogenic gene variants were identified in 13 patients (32%), including gene variation in 3 patients who were diagnosed with citrin deficiency, gene variation in 3 patients who were diagnosed with Alagille syndrome, gene variation in 3 patients who were diagnosed with progressive familial intrahepatic cholestasis type 2, gene variation in 1 patient who was diagnosed with congenital bile acid synthesis defect type 1, gene variation in 1 patient who was diagnosed with congenital bile acid synthesis defect type 1, gene variation in 1 patient who was diagnosed with Niemann-Pick disease, and gene variation in 1 patient who was diagnosed with cystic fibrosis.

CONCLUSIONS

The etiology of infantile intrahepatic cholestasis is complex. Next generation sequencing is helpful in the diagnosis of infantile intrahepatic cholestasis.

摘要

目的

探讨婴儿肝内胆汁淤积症患者的临床特征及基因检测结果。

方法

收集2017年6月至2019年6月首都儿科研究所附属儿童医院消化内科收治的疑似遗传性代谢疾病患儿的临床资料。对这些患儿采用基于目标基因panel的二代测序进行基因分析。采用桑格测序技术对该家系成员的基因进行验证。

结果

共纳入40例患者。13例(32%)患者检测到致病基因变异,其中3例诊断为瓜氨酸血症Ⅱ型,3例诊断为阿拉吉尔综合征,3例诊断为进行性家族性肝内胆汁淤积症2型,1例诊断为先天性胆汁酸合成缺陷1型,1例诊断为尼曼-匹克病,1例诊断为囊性纤维化。

结论

婴儿肝内胆汁淤积症病因复杂。二代测序有助于婴儿肝内胆汁淤积症的诊断。

相似文献

1
[Clinical characteristics and gene variants of patients with infantile intrahepatic cholestasis].[婴儿期肝内胆汁淤积症患者的临床特征与基因变异]
Zhongguo Dang Dai Er Ke Za Zhi. 2021 Jan;23(1):91-97. doi: 10.7499/j.issn.1008-8830.2009079.
2
Diagnostic algorithm for neonatal intrahepatic cholestasis integrating single-gene testing and next-generation sequencing in East Asia.东亚地区整合单基因检测与下一代测序技术的新生儿肝内胆汁淤积症诊断算法
J Gastroenterol Hepatol. 2024 May;39(5):964-974. doi: 10.1111/jgh.16505. Epub 2024 Feb 7.
3
[Analysis of clinical and genetic variation in neonatal intrahepatic cholestasis caused by citrin deficiency].[瓜氨酸血症Ⅱ型所致新生儿肝内胆汁淤积症的临床与基因变异分析]
Zhonghua Gan Zang Bing Za Zhi. 2023 Oct 20;31(10):1081-1086. doi: 10.3760/cma.j.cn501113-20220624-00345.
4
Diagnostic Yield of an Algorithm for Neonatal and Infantile Cholestasis Integrating Next-Generation Sequencing.基于下一代测序的新生儿和婴儿胆汁淤积症算法的诊断效果。
J Pediatr. 2019 Aug;211:54-62.e4. doi: 10.1016/j.jpeds.2019.04.016. Epub 2019 May 31.
5
[Analysis of SLC25A13 gene variants in 16 infants with intrahepatic cholestasis caused by citrin protein deficiency].16例因瓜氨酸蛋白缺乏引起肝内胆汁淤积症婴儿的SLC25A13基因变异分析
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2022 Feb 10;39(2):139-142. doi: 10.3760/cma.j.cn511374-20201212-00872.
6
Oxysterol/chitotriosidase based selective screening for Niemann-Pick type C in infantile cholestasis syndrome patients.基于氧化固醇/壳三糖酶的尼曼-匹克 C 型选择性筛查在婴儿胆汁淤积综合征患者中的应用。
BMC Med Genet. 2019 Jul 11;20(1):123. doi: 10.1186/s12881-019-0857-0.
7
[SLC25A13 gene mutation analysis in a pedigree of neonatal intrahepatic cholestasis caused by citrin deficiency].[柠檬酸转运蛋白缺乏所致新生儿肝内胆汁淤积症家系的SLC25A13基因突变分析]
Zhonghua Er Ke Za Zhi. 2007 Jun;45(6):408-12.
8
[Analysis of the etiology and clinical indicators of infantile cholestasis].[婴儿胆汁淤积症的病因及临床指标分析]
Zhonghua Gan Zang Bing Za Zhi. 2024 Sep 20;32(9):813-819. doi: 10.3760/cma.j.cn501113-20230905-00091.
9
Molecular Genetic Dissection and Neonatal/Infantile Intrahepatic Cholestasis Using Targeted Next-Generation Sequencing.采用靶向下一代测序进行分子遗传剖析及新生儿/婴儿期肝内胆汁淤积症
J Pediatr. 2016 Apr;171:171-7.e1-4. doi: 10.1016/j.jpeds.2016.01.006. Epub 2016 Feb 5.
10
[Analysis of clinical features and SLC25A13 gene mutations in a family affected with neonatal intrahepatic cholestasis].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2016 Oct;33(5):670-3. doi: 10.3760/cma.j.issn.1003-9406.2016.05.020.

引用本文的文献

1
Clinical characteristics and genetic analysis of neonatal intrahepatic cholestasis caused by citrin deficiency in comparison with idiopathic neonatal cholestasis.与特发性新生儿胆汁淤积症相比, citrin 缺乏症导致的新生儿肝内胆汁淤积的临床特征和基因分析。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021 Aug 25;50(4):506-513. doi: 10.3724/zdxbyxb-2021-0264.

本文引用的文献

1
Targeted Next-Generation Sequencing in Diagnostic Approach to Monogenic Cholestatic Liver Disorders-Single-Center Experience.靶向二代测序在单基因胆汁淤积性肝病诊断方法中的应用——单中心经验
Front Pediatr. 2020 Jul 24;8:414. doi: 10.3389/fped.2020.00414. eCollection 2020.
2
Neonatal cholestasis due to citrin deficiency: diagnostic pitfalls.先天性 citrin 缺陷导致的新生儿胆汁淤积症:诊断陷阱。
Acta Biochim Pol. 2020 May 21;67(2):225-228. doi: 10.18388/abp.2020_5202.
3
Alagille syndrome mutation update: Comprehensive overview of JAG1 and NOTCH2 mutation frequencies and insight into missense variant classification.Alagille 综合征突变更新:Jag1 和 Notch2 突变频率的综合概述及错义变异分类的深入了解。
Hum Mutat. 2019 Dec;40(12):2197-2220. doi: 10.1002/humu.23879. Epub 2019 Aug 26.
4
Current treatment for citrin deficiency during NICCD and adaptation/compensation stages: Strategy to prevent CTLN2.目前针对尼曼匹克 C 型疾病(NICCD)和适应/代偿期 citrin 缺乏症的治疗:预防 CTLN2 的策略。
Mol Genet Metab. 2019 Jul;127(3):175-183. doi: 10.1016/j.ymgme.2019.06.004. Epub 2019 Jun 15.
5
Diagnostic Yield of an Algorithm for Neonatal and Infantile Cholestasis Integrating Next-Generation Sequencing.基于下一代测序的新生儿和婴儿胆汁淤积症算法的诊断效果。
J Pediatr. 2019 Aug;211:54-62.e4. doi: 10.1016/j.jpeds.2019.04.016. Epub 2019 May 31.
6
Risk factors associated with mortality in neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) and clinical implications.与 citrin 缺乏症(NICCD)引起的新生儿肝内胆汁淤积症(NICCD)相关的死亡风险因素及其临床意义。
BMC Pediatr. 2019 Jan 14;19(1):18. doi: 10.1186/s12887-018-1383-5.
7
Infant cholestasis patient with a novel missense mutation in the gene successfully treated by early adequate supplementation with chenodeoxycholic acid: A case report and review of the literature.婴儿胆汁淤积症患者在基因中存在新的错义突变,通过早期充分补充鹅去氧胆酸成功治疗:病例报告及文献复习。
World J Gastroenterol. 2018 Sep 21;24(35):4086-4092. doi: 10.3748/wjg.v24.i35.4086.
8
Systematic Review: The Epidemiology, Natural History, and Burden of Alagille Syndrome.系统评价:Alagille 综合征的流行病学、自然史和负担。
J Pediatr Gastroenterol Nutr. 2018 Aug;67(2):148-156. doi: 10.1097/MPG.0000000000001958.
9
Liver disease in patients with cystic fibrosis.囊性纤维化患者的肝脏疾病
Curr Opin Gastroenterol. 2018 May;34(3):146-151. doi: 10.1097/MOG.0000000000000432.
10
Molecular diagnosis of citrin deficiency in an infant with intrahepatic cholestasis: identification of a 21.7kb gross deletion that completely silences the transcriptional and translational expression of the affected allele.肝内胆汁淤积症婴儿中柠檬酸转运蛋白缺乏症的分子诊断:鉴定出一个21.7kb的大片段缺失,该缺失完全沉默了受影响等位基因的转录和翻译表达。
Oncotarget. 2017 Aug 3;8(50):87182-87193. doi: 10.18632/oncotarget.19901. eCollection 2017 Oct 20.